icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
x27EwJJWXnveemZx
Listen
